Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Revamped Website
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1169)
•••
Comment by Pandoraon Sep 27, 2022 9:12pm
62 Views
Post# 34990980

RE:RE:RE:Revamped Website

RE:RE:RE:Revamped Website
Jennifer2020 wrote:
You bashers really need more training. Click on investors and look around from there. The buttons won't break you can explore what a huge market vpt would appeal to and what they've done to institute studies using vms+ to monitor these conditions


You sound like you are related to jopatcio -- you recognize everybody else as a basher - the height of stupidity?

Maybe if it wasn't so much trouble for you, you could have mentioned it was something under the Investor's tab or, again, if it wasn't so much trouble you could have even posted the Investor's link - but maybe your buttons broke. Enjoy your evening but watchout for bashers - they're everywhere! Except you and Jo -- what is it they say about birds of a feather?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities